Pilot study designed to assess functionality of a low-cost negative pressure wound therapy system in patients with chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, ulcers (such as diabetic, pressure, or venous insufficiency), flaps, grafts and surgical incisions

Healyx Labs0 个研究点目标入组 15 人开始时间: 2018年5月30日最近更新: 2018年6月18日

试验速览

暂无简介。

•1. Patient is 18 years of age or older
•2. Patient presents with an open wound
•3. Patient is able to understand study requirements, is willing to undergo subject procedures, provide any required subject feedback, and provide informed consent to participate in the study

•1. Patient who is pregnant or nursing
•2. Patient with a non-survivable wound, life expectancy of 7 days or less
•3. Patient’s wound is of malignant or vasculitis origin, or shows presence of necrotic tissue
•4. Patient’s wound has active bleeding, exposed blood vessels or organs
•5. Patient with wound-related comorbidities, including diabetic ketoacidosis, Hyperglycaemic Hyperosmolar Nonketotic Coma, vascular disease, or arthritis
•6. Patient currently using medications that cause immune suppression
•7. Patient with wound considered too difficult to seal based on location
•8. Patient unable to understand study or provide informed consent to participate in the study

发起方

Healyx Labs